SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Lymphatic Disorder Management in Pediatric Patients With Congenital Heart Disease in European Pediatric Cardiology Centers: Current Status, Disparities, and Future Considerations.

Safi, S; Hjortdal, VE; Gewillig, M; Miller, O; Abumehdi, MR; Cantinotti, M; Grotenhuis, H; Raimondi, F; Garrido, AO; Roest, A; et al. Safi, S; Hjortdal, VE; Gewillig, M; Miller, O; Abumehdi, MR; Cantinotti, M; Grotenhuis, H; Raimondi, F; Garrido, AO; Roest, A; Sunnegårdh, J; Saleats, T; Brun, H; Pärna, H; Nolan, O; Rotés, AS; Deri, A; De Wolf, D; Herberg, U; Liuba, P; Möller, T; Óskarsson, G; Rebonato, M; Helbing, WA; Doros, G; Muntean, I; Ojala, T; Lubaua, I; Bhat, M; Wacker, J; Bonello, B; Ramcharan, T; Greil, G; Sendzikaite, S; Bonnet, D; Marek, J; Voges, I; McMahon, CJ (2024) Lymphatic Disorder Management in Pediatric Patients With Congenital Heart Disease in European Pediatric Cardiology Centers: Current Status, Disparities, and Future Considerations. Journal of the American Heart Association, 13 (22). e036597. ISSN 2047-9980 https://doi.org/10.1161/jaha.124.036597
SGUL Authors: Ramcharan, Tristan

[img] PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB)
[img] PDF (Data S1. Supplemental Methods) Supporting information
Download (174kB)

Abstract

Background Lymphatic disorders such as protein-losing enteropathy, plastic bronchitis, and chylothorax are important complications of the Fontan circulation and ultimately result in an increased risk of early death. Several European centers are now performing lymphatic procedures. The aim of this study is to map the extent of these lymphatic disorders and treatments provided across European pediatric cardiology centers. Methods and results A survey was circulated to 49 European pediatric cardiology centers consisting of 37 questions including a mix of binary, categorical, and continuous variables. Thirty-one centers (63%) participated in the study, performing a median of 250 (interquartile range, 178 - 313) cardiopulmonary bypass procedures per year. Chylothorax emerged as the most prevalent lymphatic disorder followed by protein-losing enteropathy and plastic bronchitis. The most common diagnostic investigation method was noncontrast magnetic resonance lymphangiography (52%). Eleven centers (35%) conducted lymphatic interventions with a median of 3 (interquartile range, 1 - 4) procedures per year and 12 (interquartile range, 5 - 15) interventions in total per center. Conclusions This study confirms the rarity of and variation in treatment approaches for lymphatic disorders across Europe. With at least 11 centers offering lymphatic interventions, the adoption of these procedures is on the rise in Europe. To improve the quality of care and treatment outcomes for these complex patients, it is crucial to consider evidence-based lymphatic diagnostics, interventional lymphatic procedures, and the centralization of services in Europe.

Item Type: Article
Additional Information: © 2024 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Keywords: Humans, Heart Defects, Congenital, Lymphatic Diseases, Lymphography, Fontan Procedure, Health Care Surveys, Child, Child, Preschool, Cardiac Care Facilities, Europe, Healthcare Disparities, Practice Patterns, Physicians'
SGUL Research Institute / Research Centre: Academic Structure > Cardiovascular & Genomics Research Institute
Academic Structure > Cardiovascular & Genomics Research Institute > Clinical Cardiology
Journal or Publication Title: Journal of the American Heart Association
ISSN: 2047-9980
Language: eng
Media of Output: Print-Electronic
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
NNF23OC0082100Novo Nordisk Fondenhttps://doi.org/10.13039/501100009708
PubMed ID: 39508150
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/117413
Publisher's version: https://doi.org/10.1161/jaha.124.036597

Actions (login required)

Edit Item Edit Item